NEW YORK (GenomeWeb) – Biocartis and Fast-track Diagnostics announced on Wednesday that they have formed a strategic collaboration to develop a range of multiplex tests for infectious diseases.

Under the arrangement, the companies will develop tests based on Fast-track's PCR-based infectious disease menu for use on Biocartis' Idylla automated molecular diagnostics platform. The first assay to be developed is expected to be a multiplex respiratory panel for the detection of viral and bacterial targets in upper respiratory tract infections.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.